Global Antiretroviral Agent Market Insights, Forecast to 2029

Global Antiretroviral Agent Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Antiretroviral Agent Product Introduction
1.2 Market by Type
1.2.1 Global Antiretroviral Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 HIV Integrase Strand Transfer Inhibitors
1.2.5 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.6 Entry Inhibitors—CCR5 Co-Receptor Antagonist
1.2.7 Fusion Inhibitors
1.2.8 Others
1.3 Market by Application
1.3.1 Global Antiretroviral Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Agent Sales Estimates and Forecasts 2018-2029
2.2 Global Antiretroviral Agent Revenue by Region
2.2.1 Global Antiretroviral Agent Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antiretroviral Agent Revenue by Region (2018-2023)
2.2.3 Global Antiretroviral Agent Revenue by Region (2024-2029)
2.2.4 Global Antiretroviral Agent Revenue Market Share by Region (2018-2029)
2.3 Global Antiretroviral Agent Sales Estimates and Forecasts 2018-2029
2.4 Global Antiretroviral Agent Sales by Region
2.4.1 Global Antiretroviral Agent Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antiretroviral Agent Sales by Region (2018-2023)
2.4.3 Global Antiretroviral Agent Sales by Region (2024-2029)
2.4.4 Global Antiretroviral Agent Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antiretroviral Agent Sales by Manufacturers
3.1.1 Global Antiretroviral Agent Sales by Manufacturers (2018-2023)
3.1.2 Global Antiretroviral Agent Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiretroviral Agent in 2022
3.2 Global Antiretroviral Agent Revenue by Manufacturers
3.2.1 Global Antiretroviral Agent Revenue by Manufacturers (2018-2023)
3.2.2 Global Antiretroviral Agent Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Antiretroviral Agent Revenue in 2022
3.3 Global Key Players of Antiretroviral Agent, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Antiretroviral Agent Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antiretroviral Agent, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antiretroviral Agent, Product Offered and Application
3.8 Global Key Manufacturers of Antiretroviral Agent, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antiretroviral Agent Sales by Type
4.1.1 Global Antiretroviral Agent Historical Sales by Type (2018-2023)
4.1.2 Global Antiretroviral Agent Forecasted Sales by Type (2024-2029)
4.1.3 Global Antiretroviral Agent Sales Market Share by Type (2018-2029)
4.2 Global Antiretroviral Agent Revenue by Type
4.2.1 Global Antiretroviral Agent Historical Revenue by Type (2018-2023)
4.2.2 Global Antiretroviral Agent Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antiretroviral Agent Revenue Market Share by Type (2018-2029)
4.3 Global Antiretroviral Agent Price by Type
4.3.1 Global Antiretroviral Agent Price by Type (2018-2023)
4.3.2 Global Antiretroviral Agent Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antiretroviral Agent Sales by Application
5.1.1 Global Antiretroviral Agent Historical Sales by Application (2018-2023)
5.1.2 Global Antiretroviral Agent Forecasted Sales by Application (2024-2029)
5.1.3 Global Antiretroviral Agent Sales Market Share by Application (2018-2029)
5.2 Global Antiretroviral Agent Revenue by Application
5.2.1 Global Antiretroviral Agent Historical Revenue by Application (2018-2023)
5.2.2 Global Antiretroviral Agent Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antiretroviral Agent Revenue Market Share by Application (2018-2029)
5.3 Global Antiretroviral Agent Price by Application
5.3.1 Global Antiretroviral Agent Price by Application (2018-2023)
5.3.2 Global Antiretroviral Agent Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antiretroviral Agent Market Size by Type
6.1.1 US & Canada Antiretroviral Agent Sales by Type (2018-2029)
6.1.2 US & Canada Antiretroviral Agent Revenue by Type (2018-2029)
6.2 US & Canada Antiretroviral Agent Market Size by Application
6.2.1 US & Canada Antiretroviral Agent Sales by Application (2018-2029)
6.2.2 US & Canada Antiretroviral Agent Revenue by Application (2018-2029)
6.3 US & Canada Antiretroviral Agent Market Size by Country
6.3.1 US & Canada Antiretroviral Agent Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antiretroviral Agent Sales by Country (2018-2029)
6.3.3 US & Canada Antiretroviral Agent Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antiretroviral Agent Market Size by Type
7.1.1 Europe Antiretroviral Agent Sales by Type (2018-2029)
7.1.2 Europe Antiretroviral Agent Revenue by Type (2018-2029)
7.2 Europe Antiretroviral Agent Market Size by Application
7.2.1 Europe Antiretroviral Agent Sales by Application (2018-2029)
7.2.2 Europe Antiretroviral Agent Revenue by Application (2018-2029)
7.3 Europe Antiretroviral Agent Market Size by Country
7.3.1 Europe Antiretroviral Agent Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antiretroviral Agent Sales by Country (2018-2029)
7.3.3 Europe Antiretroviral Agent Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antiretroviral Agent Market Size
8.1.1 China Antiretroviral Agent Sales (2018-2029)
8.1.2 China Antiretroviral Agent Revenue (2018-2029)
8.2 China Antiretroviral Agent Market Size by Application
8.2.1 China Antiretroviral Agent Sales by Application (2018-2029)
8.2.2 China Antiretroviral Agent Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antiretroviral Agent Market Size by Type
9.1.1 Asia Antiretroviral Agent Sales by Type (2018-2029)
9.1.2 Asia Antiretroviral Agent Revenue by Type (2018-2029)
9.2 Asia Antiretroviral Agent Market Size by Application
9.2.1 Asia Antiretroviral Agent Sales by Application (2018-2029)
9.2.2 Asia Antiretroviral Agent Revenue by Application (2018-2029)
9.3 Asia Antiretroviral Agent Sales by Region
9.3.1 Asia Antiretroviral Agent Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antiretroviral Agent Revenue by Region (2018-2029)
9.3.3 Asia Antiretroviral Agent Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antiretroviral Agent Market Size by Type
10.1.1 Middle East, Africa and Latin America Antiretroviral Agent Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antiretroviral Agent Market Size by Application
10.2.1 Middle East, Africa and Latin America Antiretroviral Agent Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antiretroviral Agent Sales by Country
10.3.1 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antiretroviral Agent Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Information
11.1.2 ViiV Healthcare Overview
11.1.3 ViiV Healthcare Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 ViiV Healthcare Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ViiV Healthcare Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Gilead Sciences Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GlaxoSmithKline Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Information
11.4.2 Merck Sharp and Dohme Overview
11.4.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Merck Sharp and Dohme Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Sharp and Dohme Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Bristol-Myers Squibb Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Janssen Pharmaceuticals
11.6.1 Janssen Pharmaceuticals Company Information
11.6.2 Janssen Pharmaceuticals Overview
11.6.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Janssen Pharmaceuticals Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Janssen Pharmaceuticals Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Pfizer Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Overview
11.8.3 Boehringer Ingelheim Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Boehringer Ingelheim Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boehringer Ingelheim Recent Developments
11.9 AbbVie
11.9.1 AbbVie Company Information
11.9.2 AbbVie Overview
11.9.3 AbbVie Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 AbbVie Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AbbVie Recent Developments
11.10 Genentech
11.10.1 Genentech Company Information
11.10.2 Genentech Overview
11.10.3 Genentech Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Genentech Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Genentech Recent Developments
11.11 Mylan
11.11.1 Mylan Company Information
11.11.2 Mylan Overview
11.11.3 Mylan Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Mylan Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antiretroviral Agent Industry Chain Analysis
12.2 Antiretroviral Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiretroviral Agent Production Mode & Process
12.4 Antiretroviral Agent Sales and Marketing
12.4.1 Antiretroviral Agent Sales Channels
12.4.2 Antiretroviral Agent Distributors
12.5 Antiretroviral Agent Customers
13 Market Dynamics
13.1 Antiretroviral Agent Industry Trends
13.2 Antiretroviral Agent Market Drivers
13.3 Antiretroviral Agent Market Challenges
13.4 Antiretroviral Agent Market Restraints
14 Key Findings in The Global Antiretroviral Agent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antiretroviral Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors
Table 3. Major Manufacturers of Protease Inhibitors
Table 4. Major Manufacturers of HIV Integrase Strand Transfer Inhibitors
Table 5. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 6. Major Manufacturers of Entry Inhibitors—CCR5 Co-Receptor Antagonist
Table 7. Major Manufacturers of Fusion Inhibitors
Table 8. Major Manufacturers of Others
Table 9. Global Antiretroviral Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Antiretroviral Agent Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Antiretroviral Agent Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Antiretroviral Agent Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global Antiretroviral Agent Revenue Market Share by Region (2018-2023)
Table 14. Global Antiretroviral Agent Revenue Market Share by Region (2024-2029)
Table 15. Global Antiretroviral Agent Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Antiretroviral Agent Sales by Region (2018-2023) & (K Units)
Table 17. Global Antiretroviral Agent Sales by Region (2024-2029) & (K Units)
Table 18. Global Antiretroviral Agent Sales Market Share by Region (2018-2023)
Table 19. Global Antiretroviral Agent Sales Market Share by Region (2024-2029)
Table 20. Global Antiretroviral Agent Sales by Manufacturers (2018-2023) & (K Units)
Table 21. Global Antiretroviral Agent Sales Share by Manufacturers (2018-2023)
Table 22. Global Antiretroviral Agent Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Antiretroviral Agent Revenue Share by Manufacturers (2018-2023)
Table 24. Global Key Players of Antiretroviral Agent, Industry Ranking, 2021 VS 2022 VS 2023
Table 25. Antiretroviral Agent Price by Manufacturers 2018-2023 (US$/Unit)
Table 26. Global Antiretroviral Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Antiretroviral Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Agent as of 2022)
Table 28. Global Key Manufacturers of Antiretroviral Agent, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Antiretroviral Agent, Product Offered and Application
Table 30. Global Key Manufacturers of Antiretroviral Agent, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antiretroviral Agent Sales by Type (2018-2023) & (K Units)
Table 33. Global Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 34. Global Antiretroviral Agent Sales Share by Type (2018-2023)
Table 35. Global Antiretroviral Agent Sales Share by Type (2024-2029)
Table 36. Global Antiretroviral Agent Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global Antiretroviral Agent Revenue Share by Type (2018-2023)
Table 39. Global Antiretroviral Agent Revenue Share by Type (2024-2029)
Table 40. Antiretroviral Agent Price by Type (2018-2023) & (US$/Unit)
Table 41. Global Antiretroviral Agent Price Forecast by Type (2024-2029) & (US$/Unit)
Table 42. Global Antiretroviral Agent Sales by Application (2018-2023) & (K Units)
Table 43. Global Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 44. Global Antiretroviral Agent Sales Share by Application (2018-2023)
Table 45. Global Antiretroviral Agent Sales Share by Application (2024-2029)
Table 46. Global Antiretroviral Agent Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global Antiretroviral Agent Revenue Share by Application (2018-2023)
Table 49. Global Antiretroviral Agent Revenue Share by Application (2024-2029)
Table 50. Antiretroviral Agent Price by Application (2018-2023) & (US$/Unit)
Table 51. Global Antiretroviral Agent Price Forecast by Application (2024-2029) & (US$/Unit)
Table 52. US & Canada Antiretroviral Agent Sales by Type (2018-2023) & (K Units)
Table 53. US & Canada Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 54. US & Canada Antiretroviral Agent Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada Antiretroviral Agent Sales by Application (2018-2023) & (K Units)
Table 57. US & Canada Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 58. US & Canada Antiretroviral Agent Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada Antiretroviral Agent Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada Antiretroviral Agent Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada Antiretroviral Agent Sales by Country (2018-2023) & (K Units)
Table 64. US & Canada Antiretroviral Agent Sales by Country (2024-2029) & (K Units)
Table 65. Europe Antiretroviral Agent Sales by Type (2018-2023) & (K Units)
Table 66. Europe Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 67. Europe Antiretroviral Agent Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe Antiretroviral Agent Sales by Application (2018-2023) & (K Units)
Table 70. Europe Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 71. Europe Antiretroviral Agent Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe Antiretroviral Agent Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Antiretroviral Agent Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe Antiretroviral Agent Sales by Country (2018-2023) & (K Units)
Table 77. Europe Antiretroviral Agent Sales by Country (2024-2029) & (K Units)
Table 78. China Antiretroviral Agent Sales by Type (2018-2023) & (K Units)
Table 79. China Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 80. China Antiretroviral Agent Revenue by Type (2018-2023) & (US$ Million)
Table 81. China Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 82. China Antiretroviral Agent Sales by Application (2018-2023) & (K Units)
Table 83. China Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 84. China Antiretroviral Agent Revenue by Application (2018-2023) & (US$ Million)
Table 85. China Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia Antiretroviral Agent Sales by Type (2018-2023) & (K Units)
Table 87. Asia Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 88. Asia Antiretroviral Agent Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia Antiretroviral Agent Sales by Application (2018-2023) & (K Units)
Table 91. Asia Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 92. Asia Antiretroviral Agent Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia Antiretroviral Agent Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia Antiretroviral Agent Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia Antiretroviral Agent Sales by Region (2018-2023) & (K Units)
Table 98. Asia Antiretroviral Agent Sales by Region (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Antiretroviral Agent Sales by Type (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Antiretroviral Agent Sales by Application (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 105. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Antiretroviral Agent Sales by Country (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Antiretroviral Agent Sales by Country (2024-2029) & (K Units)
Table 112. ViiV Healthcare Company Information
Table 113. ViiV Healthcare Description and Major Businesses
Table 114. ViiV Healthcare Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. ViiV Healthcare Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. ViiV Healthcare Recent Developments
Table 117. Gilead Sciences Company Information
Table 118. Gilead Sciences Description and Major Businesses
Table 119. Gilead Sciences Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Gilead Sciences Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Gilead Sciences Recent Developments
Table 122. GlaxoSmithKline Company Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. GlaxoSmithKline Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GlaxoSmithKline Recent Developments
Table 127. Merck Sharp and Dohme Company Information
Table 128. Merck Sharp and Dohme Description and Major Businesses
Table 129. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Merck Sharp and Dohme Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Merck Sharp and Dohme Recent Developments
Table 132. Bristol-Myers Squibb Company Information
Table 133. Bristol-Myers Squibb Description and Major Businesses
Table 134. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Bristol-Myers Squibb Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bristol-Myers Squibb Recent Developments
Table 137. Janssen Pharmaceuticals Company Information
Table 138. Janssen Pharmaceuticals Description and Major Businesses
Table 139. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Janssen Pharmaceuticals Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Janssen Pharmaceuticals Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Pfizer Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. Boehringer Ingelheim Company Information
Table 148. Boehringer Ingelheim Description and Major Businesses
Table 149. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Boehringer Ingelheim Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Boehringer Ingelheim Recent Developments
Table 152. AbbVie Company Information
Table 153. AbbVie Description and Major Businesses
Table 154. AbbVie Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. AbbVie Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. AbbVie Recent Developments
Table 157. Genentech Company Information
Table 158. Genentech Description and Major Businesses
Table 159. Genentech Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Genentech Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Genentech Recent Developments
Table 162. Mylan Company Information
Table 163. Mylan Description and Major Businesses
Table 164. Mylan Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. Mylan Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Mylan Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Antiretroviral Agent Distributors List
Table 170. Antiretroviral Agent Customers List
Table 171. Antiretroviral Agent Market Trends
Table 172. Antiretroviral Agent Market Drivers
Table 173. Antiretroviral Agent Market Challenges
Table 174. Antiretroviral Agent Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Agent Product Picture
Figure 2. Global Antiretroviral Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antiretroviral Agent Market Share by Type in 2022 & 2029
Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 5. Protease Inhibitors Product Picture
Figure 6. HIV Integrase Strand Transfer Inhibitors Product Picture
Figure 7. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 8. Entry Inhibitors—CCR5 Co-Receptor Antagonist Product Picture
Figure 9. Fusion Inhibitors Product Picture
Figure 10. Others Product Picture
Figure 11. Global Antiretroviral Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global Antiretroviral Agent Market Share by Application in 2022 & 2029
Figure 13. Hospital Pharmacies
Figure 14. Retail Pharmacies
Figure 15. Online Pharmacies
Figure 16. Others
Figure 17. Antiretroviral Agent Report Years Considered
Figure 18. Global Antiretroviral Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Antiretroviral Agent Revenue 2018-2029 (US$ Million)
Figure 20. Global Antiretroviral Agent Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 21. Global Antiretroviral Agent Revenue Market Share by Region (2018-2029)
Figure 22. Global Antiretroviral Agent Sales 2018-2029 ((K Units)
Figure 23. Global Antiretroviral Agent Sales Market Share by Region (2018-2029)
Figure 24. US & Canada Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 25. US & Canada Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 27. Europe Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 29. China Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 31. Asia (excluding China) Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 33. Middle East, Africa and Latin America Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The Antiretroviral Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 35. The Top 5 and 10 Largest Manufacturers of Antiretroviral Agent in the World: Market Share by Antiretroviral Agent Revenue in 2022
Figure 36. Global Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 38. Global Antiretr

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs